Delcath Systems (DCTH-Q) Stock Predictions - Stockchase
WATCH LIST
2
Delcath Systems (DCTH-Q)

ON STOCKCHASE SINCE Jul 2010

Delisted to OTC (Sept 2017)

Consumer Products

Delcath Systems

DCTH-Q

3 watching          
Join the Discussion

Delcath Systems (DCTH-Q) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about DCTH-Q



  • All
  • Filtered
Signal Opinion Expert
COMMENT
Delcath Systems(DCTH-Q) 

February 11, 2011

Will have an FDA decision in July. Whether they get approval or not, there will be a huge move up or down. Options strategy? Market knows this is going to have an impact so this gets priced into the options. Very difficult to do this.
Consumer Products
0 0 0 0 0
0 comments
Will have an FDA decision in July. Whether they get approval or not, there will be a huge move up or down. Options strategy? Market knows this is going to have an impact so this gets priced into the options. Very difficult to do this.
Consumer Products
0 0 0 0 0
0 comments
Richard Croft

President, R.N. Croft Financial...

Price Price
$11.040
Owned Owned
Unknown

TOP PICK
Delcath Systems(DCTH-Q) 

July 22, 2010

Liver cancer treatment. They isolate the liver and then pump more chemo to kill cancer cells. Survivor rate has gone from 4 to 23 months. Market potential is about 5-6 billion globally. Stock dropped when a scientist said it wouldn't work but FDA protocol showed results were significant.
Consumer Products
0 0 0 0 0
0 comments
Liver cancer treatment. They isolate the liver and then pump more chemo to kill cancer cells. Survivor rate has gone from 4 to 23 months. Market potential is about 5-6 billion globally. Stock dropped when a scientist said it wouldn't work but FDA protocol showed results were significant.
Consumer Products
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$7.430
Owned Owned
Yes

Showing 1 to 2 of 2 entries
Successfully Saved Company
Successfully Saved Company